Adalimumab biosimilar market shares have steadily increased, but challenges remain due to pricing strategies and limited government support, according to the Samsung Bioepis report.

Insulin Biosimilar MarketThe global insulin biosimilar market is on track for significant expansion, with an estimated valuation of approximately USD 3,008.0 million in 2024. Exhibiting a year-on-year ...

Renee Rucinsky, DVM, DABVP, discussed insulin therapy and SGLT2 inhibitors in her lecture at the Fetch dvm360 conference in Atlantic City ...

A recent study conducted by researchers from The GRADE Study Research Group looked at how well different medications work ...

Although HbA1c testing remains the gold standard for glucose monitoring in type 1 and type 2 diabetes, limitations include ...

A major study has provided new insights into how well different medications work to control type 2 diabetes when used ...

RIVERTON (WNE) — When Kathleen Pehringer’s daughter came home from school, her mother wasn’t there. Kathleen’s purse and ...

A settlement by Wyoming Attorney General Bridget Hill guarantees that residents who are not enrolled in government health ...

Wyoming's virtual cybersecurity conference set for Oct. 23; Wyoming delegation demands answers on non-citizen voting; Tax Facts Lunch & Learn webinar tackles Amendment A; High-ene ...